Frazier Management LLC Aclaris Therapeutics, Inc. Transaction History

Frazier Management LLC

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$9.74 - $17.92 $3.98 Million - $7.32 Million
-408,329 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$13.38 - $18.8 $503,034 - $706,804
37,596 Added 10.14%
408,329 $7.35 Million
Q2 2021

Aug 11, 2021
SELL
$17.08 - $29.6 $5.56 Million - $9.63 Million
-325,267 Reduced 46.73%
370,733 $6.51 Million
Q1 2021

May 12, 2021
BUY
$5.86 - $27.73 $4.08 Million - $19.3 Million
696,000 New
696,000 $17.5 Million

Others Institutions Holding ACRS

# of Institutions
100
Shares Held
52.2M
Call Options Held
32.4K
Put Options Held
3.3K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $79.3M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email